Bandi National Institutes of Health – NIH 2024 con tematica predefinita (schema di finanziamento R01 e R21)

Dal 04.11.2024 al 01.03.2025

NIH ha pubblicato 13 nuovi bandi di finanziamento per progetti di ricerca con tematica definita, di tipo R01, caratterizzati da tesi mature supportate da dati preliminari, R21, studi esplorativi a elevato rischio/impatto con un elevato livello di innovazione e R61/R33 per studi esplorativi con un approccio in due fasi (fase 1 nella quale viene determinata la fattibilità; fase 2 nella quale l’idea progettuale viene ulteriormente sviluppata e valutata nella sua efficacia e utilità clinica). Durata da 2 a 5 anni, con budget variabile.

- Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed);

- Cellular Models of HIV Pathogenesis within NIDDK Mission Areas (R01 Clinical Trial Not Allowed);

- Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required);

- Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed; R21 Clinical Trials Not Allowed);

- Behavioural & Integrative Treatment Development Programme (R01 Clinical Trial Optional);

- Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed);

- BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed);

- New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed);

- Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 Clinical Trial Optional; R21 Clinical Trial Optional);

- Co-infection and Cancer (R01 Clinical Trial Not Allowed);

- NCI Small Grants Programme for Cancer Research (R03 Clinical Trial Optional);

- HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 Clinical Trial Optional);

- Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed; R21 Clinical Trial Not Allowed).

Ambito disciplinare: Scienze della vita, Informatica

Destinatari: Ricercatori e professori

Chiusura call: Scadenze diverse per ciascuna call a partire dal 20/01/2025.

Contatto: collaborative.grants@unipd.it